Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8VM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,871
Award facts
- Contract value 100% obligated
- $16,870.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,870.75 delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of TRELEGY ELLIPTA 200-62.5-25 inhalation medication in a 60-dose package. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 16, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle that extends through December 2031 and serves as the primary procurement mechanism for comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal supply chain, leveraging its position as a child entity under Cencora to fulfill delivery orders for brand-name and generic medications across multiple therapeutic domains. The TRELEGY ELLIPTA delivery—a combination inhalation therapy product used for respiratory conditions—reflects the company's ongoing role in supplying essential medications to military treatment facilities and veteran healthcare systems. This award, issued with no special set-aside designation, demonstrates the contractor's capability to compete successfully in the open marketplace for federal medical procurement needs under the broader DLA pharmaceutical supply vehicle.
Quick answers
Who was awarded contract SPE2DR26FY8VM?
SPE2DR26FY8VM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FY8VM worth?
The government has obligated $16,871 on SPE2DR26FY8VM.
Is contract SPE2DR26FY8VM an order under another contract?
Yes. SPE2DR26FY8VM is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8VM competed?
The extent of competition for SPE2DR26FY8VM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award